The conventional treatment strategy for patients with atrial fibrillation who are to undergo electrical cardioversion is to prescribe warfarin for anticoagulation for three weeks before cardioversion. It has been proposed that if transesophageal echocardiography reveals no atrial thrombus, cardioversion may be performed safely after only a short period of anticoagulant therapy.
Research from JAMA Internal Medicine — Senile Systemic Amyloidosis Presenting With Heart Failure — A Comparison With Light Chain–Associated Amyloidosis